ARCOBALENO CANCER TRUST
Our aim is to support the advancement of medical research into the causes, treatments, and potential cures for all types of cancer. We plan to do so by directly funding the individuals and projects pioneering cutting edge cancer research in the UK
Financial health, per its FY2024 accounts
The accounts state that the charity held unrestricted reserves of £66,210 and restricted reserves of £110,308 as of the year end. The trustees report indicates that approximately £20,000-£30,000 is held in reserve year on year to fund future initiatives, though they reserve the right to change the reserve budget to cover expenses. The independent examiner confirmed that no material matters came to their attention regarding the accounting records or the accuracy of the accounts.
What the accounts disclose
“C. Camevale Lid Monte Campo Water Sales: £1791.68” — page 4
Trustees
- ALESSANDRO VAINELLA
- CLARE HEGARTY
- DARIO DI RIENZO
- GABRIELE MAROSO
- KATHRYN CARNEVALE
- LUCIA CARNEVALE
- LUIGI CARNEVALE
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 01/12/2024 | £36k | £61k |
| 01/12/2023 | £91k | £133k |
| 01/12/2022 | £70k | £88k |
| 01/12/2021 | £237k | £26k |
| 01/12/2020 | £39k | £35k |
Common questions
Is ARCOBALENO CANCER TRUST financially healthy?
Per its FY2024 accounts: The accounts state that the charity held unrestricted reserves of £66,210 and restricted reserves of £110,308 as of the year end. The trustees report indicates that approximately £20,000-£30,000 is held in reserve year on year to fund future initiatives, though they reserve the right to change the reserve budget to cover expenses. The independent examiner confirmed that no material matters came to their attention regarding the accounting records or the accuracy of the accounts. Its FY2024 accounts were independently examined.